Tag archive for ‘Oppenheimer Co’
Gil Tanenbaum On Monday, November 17th, 2014

NeuroDerm’s IPO Comes Up Short

– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on the NASDAQ, selling 4.5 million shares More...

Gil Tanenbaum On Sunday, September 21st, 2014

Foamix Disappointing IPO Drops Share Price to $6

Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price to only $6 from the previously expected $10 to $12 range. The More...

Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

Israeli Mediwound Begins Trading On Nasdaq

– The burns and wounds treatment developer is issuing 5 million shares at $14 each. – – Burns and wounds treatment developer Mediwound will begin trading on the US Nasdaq market today. Clal More...

Jewish Business News Service On Thursday, November 21st, 2013

Ceragon Networks raising $31.4 Million in Nasdaq Offering of Ordinary Shares

– The company will issue 14 million shares at $2.40 per share, a ten-year low. – CEO Ira Palati – Ceragon Networks Ltd. (NASDAQ: CRNT), today announced the pricing of an underwritten More...

Wordpress site Developed by Fixing WordPress Problems